Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacologic Therapies in Gastrointestinal Diseases.

The Medical clinics of North America - 1 Jul 2016

Fox Rena K, Muniraj Thiruvengadam

Abstract excerpt

Several key areas in gastroenterology pharmacotherapy are rapidly evolving, including the treatment of hepatitis C virus (HCV), irritable bowel syndrome, gastroesophageal reflux disease (GERD) and peptic ulcer disease. HCV treatment has radically changed in the past 2 years and now most patients are treatment candidates and have a high likelihood of permanent cure. Pharmacotherapy is now first-line treatment for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dietary Fiber
Share to Gastroesophageal Reflux
Share to Gastrointestinal Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Diseases

Share to Irritable Bowel Syndrome

Share to Peptic Ulcer

Share to Probiotics

Share to Proton Pump Inhibitors

Source

Identifiers

PMID: 27235617
DOI: 10.1016/j.mcna.2016.03.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacologic Therapies in Gastrointestinal Diseases.PMID 27235617Read ↗

A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.Semantic proximity Read ↗

Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.Semantic proximity Read ↗

Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.Semantic proximity Read ↗

Proton pump inhibitors and recurrent bleeding in peptic ulcer disease.Semantic proximity Read ↗

CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection.Semantic proximity Read ↗

Irritable bowel syndrome: a practical approach.Semantic proximity Read ↗

Gastroesophageal Reflux Disease.Semantic proximity Read ↗

Optimal management of severe symptomatic gastroesophageal reflux disease.Semantic proximity Read ↗

Pharmacogenetics and the Treatment of Functional Gastrointestinal DisordersSemantic proximity Read ↗

[Irritable bowel syndrome: a concise diagnostic and pharmacological therapy review].Semantic proximity Read ↗

Bibliography. Current world literature. Gastrointestinal tract.Semantic proximity Read ↗

Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.